Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: A subgroup analysis of a randomized controlled trial

Background Low birthweight (birthweight <2500 grams, g) and underweight (weight-for-age Z-score, WAZ, < -2) infants have higher risk of poor outcomes compared to their well-nourished peers. We evaluated the role of azithromycin for reducing mortality and improving growth outcomes in low birthweight and/or underweight infants. Methods Infants aged 8–27 days of age weighing ≥2500 g at enrollment in Burkina Faso were randomized 1:1 to a single, oral dose of azithromycin (20 mg/kg) or matching placebo. We evaluated mortality and anthropometric outcomes in four subgroups: 1) both low birthweight and underweight at enrollment; 2) low birthweight-only; 3) underweight-only; 4) neither low birthweight nor underweight. Findings Of 21,832 enrolled infants, 21,320 (98%) had birthweight measurements and included in this analysis. Of these, 747 (3%) were both low birthweight and underweight, 972 (5%) were low birthweight-only, 825 (4%) were underweight-only, and 18,776 (88%) were neither low birthweight nor underweight. Infants who were both low birthweight and underweight receiving azithromycin had lower odds of underweight at 6 months compared to placebo (OR 0.65, 95% CI 0.44 to 0.95), but the treatment group by subgroup interaction was not statistically significant (P = 0.06). We did not find evidence of a difference between groups for other outcomes in any subgroup. Interpretation Azithromycin may have some growth-promoting benefits for the highest risk infants, but we were unable to demonstrate a difference in most outcomes in low birthweight and underweight infants. As a secondary analysis of a trial, this study was underpowered for rare outcomes such as mortality. Trial registration ClinicalTrials.gov NCT03682653.

[1]  A. Kirolos,et al.  Neurodevelopmental, cognitive, behavioural and mental health impairments following childhood malnutrition: a systematic review , 2022, BMJ Global Health.

[2]  A. Sié,et al.  Neonatal azithromycin administration for prevention of infant mortality , 2022, NEJM evidence.

[3]  A. Nakimuli,et al.  Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda , 2021, BMJ Global Health.

[4]  Mubarek Abera,et al.  Severe malnutrition or famine exposure in childhood and cardiometabolic non-communicable disease later in life: a systematic review , 2021, BMJ Global Health.

[5]  J. Lawn,et al.  Small and sick newborn care during the COVID-19 pandemic: global survey and thematic analysis of healthcare providers’ voices and experiences , 2021, BMJ Global Health.

[6]  J. Berkley,et al.  Anthropometric Criteria for Identifying Infants Under 6 Months of Age at Risk of Morbidity and Mortality: A Systematic Review , 2021, Clinical medicine insights. Pediatrics.

[7]  J. Berkley,et al.  Antimicrobial and micronutrient interventions for the management of infants under 6 months of age identified with severe malnutrition: a literature review , 2020, PeerJ.

[8]  B. Greenwood,et al.  Priorities in reducing child mortality: Azithromycin and other interventions , 2020, PLoS medicine.

[9]  M. J. van der Laan,et al.  Early childhood linear growth failure in low- and middle-income countries , 2020, medRxiv.

[10]  Benjamin F. Arnold,et al.  Causes and consequences of child growth failure in low- and middle-income countries , 2020, medRxiv.

[11]  C. Stewart,et al.  Lipid-Based Nutrient Supplementation Reduces Child Anemia and Increases Micronutrient Status in Madagascar: A Multiarm Cluster-Randomized Controlled Trial. , 2020, The Journal of nutrition.

[12]  A. Garcia,et al.  Criteria for undernutrition screening in hospitalised infants under 6 months: a diagnostic accuracy study in a resource-poor setting , 2019, Archives of Disease in Childhood.

[13]  K. Wessells,et al.  Lipid-based nutrient supplements and all-cause mortality in children 6-24 months of age: a meta-analysis of randomized controlled trials. , 2019, The American journal of clinical nutrition.

[14]  S. West,et al.  Comparison of anthropometric indicators to predict mortality in a population-based prospective study of children under 5 years in Niger , 2019, Public Health Nutrition.

[15]  A. Sié,et al.  Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial , 2019, BMJ Open.

[16]  S. West,et al.  Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa , 2018, The New England journal of medicine.

[17]  R. Grais,et al.  Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children. , 2016, The New England journal of medicine.

[18]  H. Goldbach,et al.  Antibiotics as part of the management of severe acute malnutrition. , 2013, The New England journal of medicine.

[19]  Saraswathy Sabanathan,et al.  Child development assessment tools in low-income and middle-income countries: how can we use them more appropriately? , 2015, Archives of Disease in Childhood.

[20]  J. Ouédraogo,et al.  Small-Quantity Lipid-Based Nutrient Supplements, Regardless of Their Zinc Content, Increase Growth and Reduce the Prevalence of Stunting and Wasting in Young Burkinabe Children: A Cluster-Randomized Trial , 2015, PloS one.

[21]  C. Nylund,et al.  Azithromycin in Early Infancy and Pyloric Stenosis , 2015, Pediatrics.

[22]  Colin Mathers,et al.  Every Newborn: progress, priorities, and potential beyond survival , 2014, The Lancet.

[23]  A. Manges,et al.  The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.

[24]  R. Hennekam,et al.  Infantile hypertrophic pyloric stenosis—genetics and syndromes , 2012, Nature Reviews Gastroenterology &Hepatology.

[25]  Y. Cheung,et al.  An effectiveness trial showed lipid-based nutrient supplementation but not corn–soya blend offered a modest benefit in weight gain among 6- to 18-month-old underweight children in rural Malawi , 2012, Public Health Nutrition.